IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

ORENCIA (abatacept) injection

Brand: ORENCIA. API: abatacept is used to treat autoimmune and inflammatory joint conditions by slowing down T-cell immune activity.

Orencia (abatacept) is a prescription biologic medication used to treat autoimmune and inflammatory joint conditions by slowing down T-cell immune activity

Brand Name: ORENCIA – On Request
Generic Name: abatacept
Strength: Intravenous Infusion
• For injection: 250 mg lyophilized powder in a single-dose vial (may use less than full contents of vial or use more than one vial).
Subcutaneous Use
• Injection: 50 mg/0.4 mL, 87.5 mg/0.7 mL, 125 mg/mL solution in singledose prefilled syringes.
• Injection: 125 mg/mL solution in a single-dose prefilled ClickJect
autoinjectors.
Manufacturer: Bristol-Myers Squibb
Approved By: EMA, USFDA
Get access to medicines: In India
Price: On Request

See full prescribing information for ORENCIA: Patient Information

Get access ORENCIA to treat autoimmune and inflammatory joint conditions by slowing down T-cell immune activity on a Named Patient Import Basis.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ORENCIA (abatacept) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Categories: ,

Contact Info

CORPORATE OFFICE:

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:

info@indianpharmanetwork.co.in

    Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.
    Abatacept is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. In order for a T cell to be activated and produce an immune response, an antigen-presenting cell must present two signals to the T cell. One of those signals is the major histocompatibility complex (MHC), combined with the antigen, and the other signal is the CD80 or CD86 molecule (also known as B7-1 and B7-2). Abatacept binds to the CD80 and CD86 molecule, and prevents the second signal. Without the second signal, the T cell can't be activated.

    ORENCIA (abatacept) injection, for subcutaneous use Initial U.S. Approval: 2005

    Is ORENCIA (abatacept) available in India?

    ORENCIA (abatacept) may be accessed in India through a named-patient import process with a valid doctor’s prescription, and Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing and delivery of specialty medicines subject to regulatory approvals.

    How to get ORENCIA Injection delivered in India?

    Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations. Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.

    IPN having representation in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.

    Who can help source ORENCIA Injection in India legally?

    Named-patient import facilitator contact details
    Company Name: Indian Pharma Network (IPN)
    Address: 60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
    For sourcing and import coordination of specialty medicines, contact:
    Mr. Tarun: +91 9891 296 838
    Mr. Neeraj: +91 9811 747 774
    Email: info@indianpharmanetwork.co.in

    Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.

    Note:
    We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India.

    Indian Pharma Network (IPN), New Delhi. India

    Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
    Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
    Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

    Indian Pharma Network
    60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

    Mobile / WhatsApp / Phone
    M: +91 9811747774, 9891296838.
    P: +91-11-26532129 / 26536398